Skip to content

Study Comparing Tension-free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence

A Randomized Trial Comparing the Monarc Subfascial Hammock Procedure With Tension-free Vaginal Tape Procedure for the Surgical Treatment of Stress Urinary Incontinence

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00475839
Enrollment
180
Registered
2007-05-21
Start date
2004-12-31
Completion date
2007-07-31
Last updated
2013-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Keywords

stress urinary incontinence, sling procedures, tension-free vaginal tape, transobturator

Brief summary

Urinary incontinence is a major health issue in women. It is estimated to affect 30 - 40% of older women. Stress urinary incontinence, the most common form of this disease, is treated primarily with surgery. A woman's lifetime risk of surgery for SUI is 4%, with nearly 1/3 of surgery being performed for recurrences. Many different surgical procedures have been described for the treatment of SUI and there is no general agreement as to the most effective. This study compares the safety and efficacy of the tension-free vaginal tape procedure to the Monarc subfascial hammock procedure in the treatment of stress urinary incontinence.

Interventions

DEVICEMonarc sub-fascial hammock

Sponsors

Good Samaritan Hospital, Ohio
CollaboratorOTHER
Greater Baltimore Medical Center
CollaboratorOTHER
American Medical Systems
CollaboratorINDUSTRY
The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Urinary incontinence symptoms * Urodynamic stress incontinence confirmed with multichannel urodynamic testing * Age of at least 21 years * Desires surgical correction of stress urinary incontinence

Exclusion criteria

* Post-void residual volume \>100cc * Detrusor overactivity on preoperative multichannel urodynamic testing * History of previous synthetic, biologic or fascial sub-urethral sling * Desires future childbearing * Chronic inguinal or vulvar abscess or history of Hidradenitis Suppurativa * History of bleeding diathesis or current anti-coagulation therapy * Inguinal lymphadenopathy or inguinal/vulvar mass * Current genitourinary fistula or urethral diverticulum * Reversible cause of incontinence (i.e. drug effect) * Contraindication to surgery

Design outcomes

Primary

MeasureTime frame
The presence of abnormal bladder function, defined as the sign or symptom of urinary incontinence or urinary retention12 months

Secondary

MeasureTime frame
Postoperative pain2 weeks, 6 weeks
HRQOL6 months, 12 months, 18 months, 24 months
Complications
Global improvement in bladder function6 months, 12 months, 18 months, 24 months
Development of anterior vaginal prolapse12 months, 24 months
Sexual function12 months, 24 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026